Registered outcomes19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 19 of 19

Download this page as JSON

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05967052/registered

API reference For AI assistants

List	Outcome	Time frame	Description
Primary	Change in fatigue intensity expressed as a difference in Multidimensional Fatigue Inventory-20 (MFI-20) score	3 months and 6 months	Change in fatigue intensity expressed as a difference in Multidimensional Fatigue Inventory-20 (MFI-20) score at 3 and 6 months of the study relative to the baseline score
Primary	Walking distance as a difference in score from the 6 Minute Walking Test	3 months and 6 months	Walking distance as a difference in score from the 6 Minute Walking Test at 3 and 6 months compared to baseline
Secondary	Change in the level of satisfaction with life expressed in the form of the result of the Satisfaction with Life Scale (Juczyński)	3 months and 6 months	Change in the level of satisfaction with life expressed in the form of the result of the Satisfaction with Life Scale (Juczyński) in the 3rd and 6th month of the study in relation to the result on the day of the study
Secondary	Change in the result obtained in the "Beck Depression Inventory (BDIII)" study	3 months and 6 months	Change in the result obtained in the "Beck Depression Inventory (BDIII)" study in the 3rd and 6th month of the study in relation to the result on the day of the study commencement.
Secondary	Change in the result obtained in the anxiety test - State and Trait Anxiety Inventory (STAI)	3 months and 6 months	Change in the result obtained in the anxiety test - State and Trait Anxiety Inventory (STAI) in the 3rd and 6th month of the study in relation to the result on the day of the study commencement.
Secondary	Change in the degree of acceptance of the disease assessed by the Acceptance of Illness Scale (Juczyński) i	3 months and 6 months	Change in the degree of acceptance of the disease assessed by the Acceptance of Illness Scale (Juczyński) in the 3rd and 6th month of the study in relation to the result on the day of starting the study
Secondary	Change in the result of the CCT test	3 months and 6 months	Change in the result of the CCT test in the 3rd and 6th month of the study compared to the result on the day of starting the study.
Secondary	Change in neuropsychological assessment expressed by the change in the result of the Wisconsin Card Sorting Test (WCST)	3 months and 6 months	Change in neuropsychological assessment expressed by the change in the result of the Wisconsin Card Sorting Test (WCST) in the 3rd and 6th month of the study compared to the result on the day of the study commencement.
Secondary	Change in the result of the RFFT test	3 months and 6 months	Change in the result of the RFFT test in the 3rd and 6th month of the study compared to the result on the day of starting the study.
Secondary	Change in the WAIS-R intelligence test result	3 months and 6 months	Change in the WAIS-R intelligence test result in the 3rd and 6th month of the study in relation to the result on the day of the study commencement
Secondary	Change in reaction time expressed by the Stroop interference test	3 months and 6 months	Change in reaction time expressed by the Stroop interference test in the 3rd and 6th month of the study compared to the result on the day of the study start.
Secondary	Change in the assessment of the quality of gait	3 months and 6 months	Change in the assessment of the quality of gait in the 3rd and 6th month of the study in relation to the result on the day of the beginning of the study
Secondary	Change in walking speed	3 months and 6 months	Change in walking speed in the 3rd and 6th month of the study in relation to the result on the day of the study.
Other	The change in the profile of the examined inflammatory cytokines	3 months and 6 months	The exploratory endpoint is the change in the profile of the examined inflammatory cytokines in the 3rd and 6th month of the study in relation to the result before the start of the study.
Other	Number of adverse events and the number and percentage of patients who experienced adverse events	3 months and 6 months	Number of adverse events and the number and percentage of patient who experienced adverse events
Other	Number of adverse events and the number and proportion of patients who experienced treatment-related adverse events	3 months and 6 months	Number of adverse events and the number and proportion of patients who experienced treatment-related adverse events
Other	Number of serious adverse events and number and proportion of patients with serious adverse events.	3 months and 6 months	Number of serious adverse events and number and proportion of patients with serious adverse events.
Other	Number of serious adverse events and the number and proportion of patients who experienced treatment-related serious adverse events.	3 months and 6 months	Number of serious adverse events and the number and proportion of patients who experienced treatment-related serious adverse events.
Other	Number and percentage of patients who discontinued participation in the study due to an adverse event - changes in laboratory parameters and basic vital signs.	3 months and 6 months	Number and percentage of patients who discontinued participation in the study due to an adverse event - changes in laboratory parameters and basic vital signs.